rs143131218

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001018113.3(FANCB):​c.2452A>G​(p.Arg818Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000527 in 1,209,146 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 193 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R818S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., 9 hem., cov: 23)
Exomes 𝑓: 0.00054 ( 0 hom. 184 hem. )

Consequence

FANCB
NM_001018113.3 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.60

Publications

3 publications found
Variant links:
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
FANCB Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • VACTERL association, X-linked, with or without hydrocephalus
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • VACTERL with hydrocephalus
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06629488).
BP6
Variant X-14843695-T-C is Benign according to our data. Variant chrX-14843695-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 246615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 9 AR,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCBNM_001018113.3 linkc.2452A>G p.Arg818Gly missense_variant Exon 10 of 10 ENST00000650831.1 NP_001018123.1 Q8NB91A0A024RBW1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCBENST00000650831.1 linkc.2452A>G p.Arg818Gly missense_variant Exon 10 of 10 NM_001018113.3 ENSP00000498215.1 Q8NB91

Frequencies

GnomAD3 genomes
AF:
0.000358
AC:
40
AN:
111821
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000650
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000715
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000290
AC:
53
AN:
183032
AF XY:
0.000340
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.000601
Gnomad OTH exome
AF:
0.000443
GnomAD4 exome
AF:
0.000544
AC:
597
AN:
1097325
Hom.:
0
Cov.:
30
AF XY:
0.000507
AC XY:
184
AN XY:
362725
show subpopulations
African (AFR)
AF:
0.000190
AC:
5
AN:
26383
American (AMR)
AF:
0.0000284
AC:
1
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54110
European-Finnish (FIN)
AF:
0.0000494
AC:
2
AN:
40525
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.000679
AC:
571
AN:
841332
Other (OTH)
AF:
0.000391
AC:
18
AN:
46071
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000358
AC:
40
AN:
111821
Hom.:
0
Cov.:
23
AF XY:
0.000265
AC XY:
9
AN XY:
33985
show subpopulations
African (AFR)
AF:
0.0000650
AC:
2
AN:
30765
American (AMR)
AF:
0.00
AC:
0
AN:
10479
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3575
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2714
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000715
AC:
38
AN:
53164
Other (OTH)
AF:
0.00
AC:
0
AN:
1494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000532
Hom.:
29
Bravo
AF:
0.000329
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000446
AC:
3
ExAC
AF:
0.000321
AC:
39
EpiCase
AF:
0.000436
EpiControl
AF:
0.000474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia Benign:2
Nov 08, 2021
Sema4, Sema4
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 06, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia complementation group B Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

FANCB-related disorder Benign:1
Dec 28, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FANCB: BP4, BS2 -

VACTERL association, X-linked, with or without hydrocephalus Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.38
T;T;T
FATHMM_MKL
Benign
0.47
N
LIST_S2
Benign
0.71
T;.;T
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.049
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
L;L;.
PhyloP100
1.6
PrimateAI
Benign
0.23
T
PROVEAN
Uncertain
-3.6
D;D;D
REVEL
Benign
0.20
Sift
Benign
0.085
T;T;D
Sift4G
Uncertain
0.021
D;D;D
Polyphen
0.76
P;P;.
Vest4
0.26
MVP
0.19
MPC
0.31
ClinPred
0.087
T
GERP RS
1.6
Varity_R
0.19
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143131218; hg19: chrX-14861817; API